Magansina, Baby Boy .
HRN: 26-30-28 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/28/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
11/28/2024
12/04/2024
IV
35mg
OD
PSNB
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes